Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
109.04
+3.11 (2.94%)
At close: Jan 21, 2026, 4:00 PM EST
110.00
+0.96 (0.88%)
After-hours: Jan 21, 2026, 5:56 PM EST
Nuvalent Employees
Nuvalent had 142 employees as of December 31, 2024. The number of employees increased by 50 or 54.35% compared to the previous year.
Employees
142
Change (1Y)
50
Growth (1Y)
54.35%
Revenue / Employee
n/a
Profits / Employee
-$2,686,162
Market Cap
8.47B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 142 | 50 | 54.35% |
| Dec 31, 2023 | 92 | 30 | 48.39% |
| Dec 31, 2022 | 62 | 22 | 55.00% |
| Dec 31, 2021 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jazz Pharmaceuticals | 2,800 |
| Caris Life Sciences | 1,769 |
| Axsome Therapeutics | 816 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 673 |
| Cytokinetics | 498 |
| Halozyme Therapeutics | 350 |
| Rhythm Pharmaceuticals | 283 |
NUVL News
- 8 days ago - Nuvalent, Inc. (NUVL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Nuvalent Announces OnTarget 2026 Operating Plan Progress and Outlines Key Anticipated 2026 Milestones - PRNewsWire
- 4 weeks ago - Nuvalent to Present at the 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 6 weeks ago - Nuvalent Appoints Ron Squarer to Board of Directors - PRNewsWire
- 2 months ago - Nuvalent to Participate in the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 2 months ago - Nuvalent Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares from Selling Stockholders - PRNewsWire
- 2 months ago - Nuvalent Announces FDA Acceptance of New Drug Application for Zidesamtinib for the Treatment of TKI Pre-treated Patients with Advanced ROS1-positive NSCLC - PRNewsWire
- 2 months ago - Nuvalent Announces Pricing of Public Offering of Common Stock - PRNewsWire